Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 172

1.

[Efficacy of F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) scans in diagnosis of pulmonary nodules].

Orino K, Kawamura M, Hatazawa J, Suzuki I, Sazawa Y.

Jpn J Thorac Cardiovasc Surg. 1998 Dec;46(12):1267-74. Japanese.

PMID:
10037834
[PubMed - indexed for MEDLINE]
2.

Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.

Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP.

Chest. 1993 Oct;104(4):997-1002.

PMID:
8404239
[PubMed - indexed for MEDLINE]
3.

Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.

Higashi K, Ueda Y, Sakuma T, Seki H, Oguchi M, Taniguchi M, Taki S, Tonami H, Katsuda S, Yamamoto I.

J Nucl Med. 2001 Oct;42(10):1489-96.

PMID:
11585862
[PubMed - indexed for MEDLINE]
Free Article
4.

Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.

Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K.

Lung Cancer. 2004 Jul;45(1):19-27.

PMID:
15196730
[PubMed - indexed for MEDLINE]
5.

Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?

Hales NW, Krempl GA, Medina JE.

Am J Otolaryngol. 2008 Mar-Apr;29(2):113-8. doi: 10.1016/j.amjoto.2007.04.006.

PMID:
18314022
[PubMed - indexed for MEDLINE]
6.

The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.

Hsieh HJ, Lin SH, Lin KH, Lee CY, Chang CP, Wang SJ.

Ann Nucl Med. 2008 Jul;22(6):533-8. doi: 10.1007/s12149-007-0142-8. Epub 2008 Aug 1.

PMID:
18670862
[PubMed - indexed for MEDLINE]
7.

[The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].

Xu HF, Liu Y, Zhang JH, Zhou RS, Zhou FH, Yuan MH.

Zhonghua Jie He He Hu Xi Za Zhi. 2005 Feb;28(2):108-11. Chinese.

PMID:
15854393
[PubMed - indexed for MEDLINE]
8.

Differentiation of radiographically indeterminate solitary pulmonary nodules with.

Hung GU, Shiau YC, Tsai SC, Ho YJ, Kao CH, Yen RF.

Jpn J Clin Oncol. 2001 Feb;31(2):51-4.

PMID:
11302341
[PubMed - indexed for MEDLINE]
Free Article
9.

PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis.

Dewan NA, Reeb SD, Gupta NC, Gobar LS, Scott WJ.

Chest. 1995 Aug;108(2):441-6.

PMID:
7634881
[PubMed - indexed for MEDLINE]
10.
11.

The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules.

Herder GJ, Golding RP, Hoekstra OS, Comans EF, Teule GJ, Postmus PE, Smit EF.

Eur J Nucl Med Mol Imaging. 2004 Sep;31(9):1231-6. Epub 2004 Jun 3.

PMID:
15175835
[PubMed - indexed for MEDLINE]
12.

Performance of sodium iodide based (18)F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses.

Pitman AG, Hicks RJ, Binns DS, Ware RE, Kalff V, McKenzie AF, Ball DL, MacManus MP.

Br J Radiol. 2002 Feb;75(890):114-21.

PMID:
11893634
[PubMed - indexed for MEDLINE]
13.

18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.

Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.

Ann Surg. 2007 Dec;246(6):932-7; discussion 937-9.

PMID:
18043094
[PubMed - indexed for MEDLINE]
14.

Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size.

Tsunezuka Y, Shimizu Y, Tanaka N, Takayanagi T, Kawano M.

World J Surg. 2007 Feb;31(2):314-7.

PMID:
17219276
[PubMed - indexed for MEDLINE]
15.

The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer.

Kagna O, Solomonov A, Keidar Z, Bar-Shalom R, Fruchter O, Yigla M, Israel O, Guralnik L.

Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):997-1004. doi: 10.1007/s00259-009-1061-9. Epub 2009 Feb 5.

PMID:
19194704
[PubMed - indexed for MEDLINE]
16.

F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection.

Bakheet SM, Saleem M, Powe J, Al-Amro A, Larsson SG, Mahassin Z.

Clin Nucl Med. 2000 Apr;25(4):273-8.

PMID:
10750966
[PubMed - indexed for MEDLINE]
17.

Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.

Halley A, Hugentobler A, Icard P, Porret E, Sobrio F, Lerochais JP, Bouvard G, Zalcman G, Agostini D.

Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1026-32. Epub 2005 May 5.

PMID:
15877227
[PubMed - indexed for MEDLINE]
18.

Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.

Yap CS, Czernin J, Fishbein MC, Cameron RB, Schiepers C, Phelps ME, Weber WA.

Chest. 2006 Feb;129(2):393-401.

PMID:
16478857
[PubMed - indexed for MEDLINE]
19.

Differentiating benign and malignant pulmonary lesions with FDG-PET.

Yang SN, Liang JA, Lin FJ, Kwan AS, Kao CH, Shen YY.

Anticancer Res. 2001 Nov-Dec;21(6A):4153-7.

PMID:
11911310
[PubMed - indexed for MEDLINE]
20.

Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease.

Graeber GM, Gupta NC, Murray GF.

J Thorac Cardiovasc Surg. 1999 Apr;117(4):719-27.

PMID:
10096967
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk